<?xml version="1.0" encoding="ISO-8859-1"?><COCHRANE_REVIEW DESCRIPTION="For publication" DOI="10.1002/14651858.CD000944" GROUP_ID="PREG" ID="953599080215042396" MERGED_FROM="" MODIFIED="2008-11-05 11:50:20 +0100" MODIFIED_BY="Frances Kellie" NOTES="&lt;p&gt;Short title (no longer in use): Symphysis-fundal height measurement in pregnancy&lt;/p&gt;&lt;p&gt;&lt;/p&gt;" NOTES_MODIFIED="2008-11-05 10:48:51 +0000" NOTES_MODIFIED_BY="[Empty name]" REVIEW_NO="0152" REVMAN_SUB_VERSION="5.0.16" REVMAN_VERSION="5" SPLIT_FROM="" STAGE="R" STATUS="A" TYPE="INTERVENTION" VERSION_NO="8.0">
<COVER_SHEET MODIFIED="2008-11-05 11:50:20 +0100" MODIFIED_BY="Frances Kellie">
<TITLE>Symphysis-fundal height measurement in pregnancy</TITLE>
<CONTACT MODIFIED="2008-11-05 11:50:20 +0100" MODIFIED_BY="Frances Kellie"><PERSON ID="7935" ROLE="AUTHOR"><PREFIX>Prof</PREFIX><FIRST_NAME>James P</FIRST_NAME><LAST_NAME>Neilson</LAST_NAME><POSITION>Professor of Obstetrics and Gynaecology/Head of School of Reproductive and Developmental Medicine</POSITION><EMAIL_1>jneilson@liverpool.ac.uk</EMAIL_1><ADDRESS><DEPARTMENT>School of Reproductive and Developmental Medicine, Division of Perinatal and Reproductive Medicine</DEPARTMENT><ORGANISATION>The University of Liverpool</ORGANISATION><ADDRESS_1>First Floor, Liverpool Women's NHS Foundation Trust</ADDRESS_1><ADDRESS_2>Crown Street</ADDRESS_2><CITY>Liverpool</CITY><ZIP>L8 7SS</ZIP><COUNTRY CODE="GB">UK</COUNTRY><PHONE_1>+44 151 7024100</PHONE_1><FAX_1>+44 151 7024024</FAX_1></ADDRESS></PERSON></CONTACT>
<CREATORS MODIFIED="2008-11-05 11:50:20 +0100" MODIFIED_BY="Frances Kellie"><PERSON ID="7935" ROLE="AUTHOR"><PREFIX>Prof</PREFIX><FIRST_NAME>James P</FIRST_NAME><LAST_NAME>Neilson</LAST_NAME><POSITION>Professor of Obstetrics and Gynaecology/Head of School of Reproductive and Developmental Medicine</POSITION><EMAIL_1>jneilson@liverpool.ac.uk</EMAIL_1><ADDRESS><DEPARTMENT>School of Reproductive and Developmental Medicine, Division of Perinatal and Reproductive Medicine</DEPARTMENT><ORGANISATION>The University of Liverpool</ORGANISATION><ADDRESS_1>First Floor, Liverpool Women's NHS Foundation Trust</ADDRESS_1><ADDRESS_2>Crown Street</ADDRESS_2><CITY>Liverpool</CITY><ZIP>L8 7SS</ZIP><COUNTRY CODE="GB">UK</COUNTRY><PHONE_1>+44 151 7024100</PHONE_1><FAX_1>+44 151 7024024</FAX_1></ADDRESS></PERSON></CREATORS>
<DATES MODIFIED="2008-09-22 13:15:52 +0100" MODIFIED_BY="Lixia Dou" NOTES="&lt;p&gt;Minor update: 8/19/05&lt;/p&gt;&lt;p&gt;New studies sought but none found: 8/13/02&lt;/p&gt;&lt;p&gt;Reformatted: 8/3/99&lt;/p&gt;" NOTES_MODIFIED="2008-09-22 13:15:52 +0100" NOTES_MODIFIED_BY="Lixia Dou">
<UP_TO_DATE>
<DATE DAY="13" MONTH="8" YEAR="2002"/>
</UP_TO_DATE>
<LAST_SEARCH>
<DATE DAY="13" MONTH="8" YEAR="2002"/>
</LAST_SEARCH>
<NEXT_STAGE>
<DATE DAY="" MONTH="" YEAR=""/>
</NEXT_STAGE>
<PROTOCOL_PUBLISHED ISSUE="1" YEAR="1998"/>
<REVIEW_PUBLISHED ISSUE="1" YEAR="1998"/>
<LAST_CITATION_ISSUE ISSUE="2" YEAR="1998"/>
</DATES>
<WHATS_NEW MODIFIED="2008-11-05 10:45:41 +0000" MODIFIED_BY="[Empty name]">
<WHATS_NEW_ENTRY EVENT="AMENDMENT">
<DATE DAY="20" MONTH="9" YEAR="2008"/>
<DESCRIPTION>
<P>Converted to new review format.</P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
</WHATS_NEW>
<HISTORY MODIFIED="2008-11-05 10:48:51 +0000" MODIFIED_BY="[Empty name]">
<WHATS_NEW_ENTRY EVENT="AMENDMENT" MODIFIED="2008-11-05 10:45:41 +0000" MODIFIED_BY="[Empty name]">
<DATE DAY="3" MONTH="1" YEAR="2007"/>
<DESCRIPTION>
<P>Note added to published notes section stating that a new protocol to update this review is currently being prepared by a new review team.</P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
<WHATS_NEW_ENTRY EVENT="UPDATE" MODIFIED="2008-11-05 10:48:51 +0000" MODIFIED_BY="[Empty name]">
<DATE DAY="13" MONTH="8" YEAR="2002"/>
<DESCRIPTION>
<P>Search updated. No new studies identified.</P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
</HISTORY>
<SOURCES_OF_SUPPORT>
<INTERNAL_SOURCES>
<SOURCE>
<NAME>University of Liverpool</NAME>
<COUNTRY CODE="GB">UK</COUNTRY>
<DESCRIPTION/>
</SOURCE>
<SOURCE>
<NAME>Liverpool Women's Hospital</NAME>
<COUNTRY CODE="GB">UK</COUNTRY>
<DESCRIPTION/>
</SOURCE>
</INTERNAL_SOURCES>
<EXTERNAL_SOURCES/>
</SOURCES_OF_SUPPORT>
<MESH_TERMS VERIFIED="NO"/>
<KEYWORDS/>
</COVER_SHEET>
<MAIN_TEXT MODIFIED="2008-09-22 13:19:23 +0100" MODIFIED_BY="[Empty name]">
<SUMMARY MODIFIED="2008-09-22 13:16:44 +0100" MODIFIED_BY="[Empty name]">
<TITLE MODIFIED="2008-09-22 13:16:40 +0100" MODIFIED_BY="[Empty name]">Symphysis-fundal height measurement in pregnancy</TITLE>
<SUMMARY_BODY MODIFIED="2008-09-22 13:16:44 +0100" MODIFIED_BY="[Empty name]">
<P>Too little evidence to show whether measuring the height of the pregnant belly at antenatal visits leads to better outcomes.</P>
<P>Many pregnant women have the distance from the lowest part of their uterus (womb) (near the pubic bone) to the highest part of their uterus measured with a tape measure (symphysis fundal height). Their caregiver may also feel and gently press the outside of the woman's pregnant uterus (abdominal palpation). This is to check the baby's size and position, the quantity of fluid around the baby and to diagnose multiple pregnancy. The review found that there is too little evidence to show whether symphysis fundal height measurement during pregnancy is more beneficial than abdominal palpation. Further research is needed.</P>
</SUMMARY_BODY>
</SUMMARY>
<ABSTRACT>
<ABS_BACKGROUND>
<P>In many settings, symphysis-fundal height measurement has replaced clinical assessment of fetal size by abdominal palpation because the latter has been reported to perform poorly.</P>
</ABS_BACKGROUND>
<ABS_OBJECTIVES>
<P>The objective of this review was to assess the effects of routine use of symphysis-fundal height measurements (tape measurement of the distance from the pubic symphysis to the uterine fundus) during antenatal care on pregnancy outcome.</P>
</ABS_OBJECTIVES>
<ABS_SEARCH_STRATEGY>
<P>Comprehensive electronic search of the Cochrane Pregnancy and Childbirth Group trials register (August 2002).</P>
</ABS_SEARCH_STRATEGY>
<ABS_SELECTION_CRITERIA>
<P>Acceptably controlled trials comparing symphysis-fundal height measurement with assessment by abdominal palpation alone.</P>
</ABS_SELECTION_CRITERIA>
<ABS_DATA_COLLECTION>
<P>One reviewer assessed trial quality and extracted data.</P>
</ABS_DATA_COLLECTION>
<ABS_RESULTS>
<P>One trial involving 1639 women was included. No obvious differences were detected in any of the outcomes measured.</P>
</ABS_RESULTS>
<ABS_CONCLUSIONS>
<P>There is not enough evidence to evaluate the use of symphysis-fundal height measurements during antenatal care.</P>
</ABS_CONCLUSIONS>
</ABSTRACT>
<BODY MODIFIED="2008-09-22 13:19:23 +0100" MODIFIED_BY="[Empty name]">
<BACKGROUND>
<P>Tape measurement of symphysis-fundal height is simple, inexpensive, and widely used during antenatal care. The primary aim of the test is the detection of fetuses that are poorly grown but it also has the potential to facilitate the detection of multiple pregnancies and of fetuses that are unusually large. However, detection of fetuses that are unusually small, or large, or of unrecognised multiple pregnancies is only of importance if associated mortality or morbidity could be avoided, or if the process of care could be improved in a tangible way.</P>
<P>In many settings, symphysis-fundal height measurement has replaced clinical assessment of fetal size by abdominal palpation because the latter has been reported to perform poorly, in observational studies during routine antenatal care, in detecting fetuses that were small for gestational age at delivery - thus, detection rates between 30% and 50% have been described (<LINK REF="REF-Hall-1980" TYPE="REFERENCE">Hall 1980</LINK>; <LINK REF="REF-Rosenberg-1982" TYPE="REFERENCE">Rosenberg 1982</LINK>). Although reported detection rates of small-for-dates babies from observational studies of symphysis-fundal height measurement appear somewhat better, these have varied greatly - between, for example, 56% (<LINK REF="REF-Rosenberg-1982" TYPE="REFERENCE">Rosenberg 1982</LINK>) and 86% (<LINK REF="REF-Belizan-1978" TYPE="REFERENCE">Belizan 1978</LINK>). In addition, it has been claimed that symphysis-fundal height cannot be measured by different observers with sufficient agreement to separate small fundal heights from those that are not small (<LINK REF="REF-Bailey-1989" TYPE="REFERENCE">Bailey 1989</LINK>), thus severely limiting the use of the technique in antenatal clinics in which a woman is likely to see more than one clinician during the course of pregnancy.</P>
</BACKGROUND>
<OBJECTIVES>
<P>To assess whether the routine use of symphysis-fundal height measurement during antenatal care improves pregnancy outcome, compared to examination by abdominal palpation alone.</P>
</OBJECTIVES>
<METHODS MODIFIED="2008-09-22 13:19:23 +0100" MODIFIED_BY="[Empty name]">
<SELECTION_CRITERIA MODIFIED="2008-09-22 13:18:36 +0100" MODIFIED_BY="[Empty name]">
<CRIT_STUDIES>
<P>All acceptably controlled trials of symphysis-fundal height measurement during pregnancy, compared with abdominal palpation alone. Any future trial that compared symphysis-fundal height measurement with routine ultrasound measurements of the fetus would be included in the 'Ultrasound for fetal assessment in early pregnancy' review (<LINK REF="REF-Neilson-2003" TYPE="REFERENCE">Neilson 2003</LINK>).</P>
</CRIT_STUDIES>
<CRIT_PARTICIPANTS>
<P>Pregnant women.</P>
</CRIT_PARTICIPANTS>
<CRIT_INTERVENTIONS>
<P>Tape measurement of symphysis-fundal height.</P>
</CRIT_INTERVENTIONS>
<CRIT_OUTCOMES MODIFIED="2008-09-22 13:18:36 +0100" MODIFIED_BY="[Empty name]">
<CRIT_OUTCOMES_PRIMARY MODIFIED="2008-09-22 13:18:28 +0100" MODIFIED_BY="[Empty name]">
<P>Primary outcomes: complications associated with fetal growth restriction ('IUGR') ie intrauterine death, intrapartum asphyxia ('fetal distress' in labour), and neonatal hypoglycaemia; complications associated with fetal macrosomia (cephalopelvic disproportion (caesarean section for failure to progress), shoulder dystocia); complications associated with multiple pregnancy (preterm delivery, perinatal mortality).</P>
</CRIT_OUTCOMES_PRIMARY>
<CRIT_OUTCOMES_SECONDARY MODIFIED="2008-09-22 13:18:33 +0100" MODIFIED_BY="[Empty name]">
<P>Secondary outcomes: other indices of maternal and perinatal mortality and morbidity; indices of obstetric care, including admission to hospital.</P>
<P>If possible, future reviews would include sub-group analyses based on the availability, or not, of ultrasound investigation of fetal growth and wellbeing.</P>
</CRIT_OUTCOMES_SECONDARY>
</CRIT_OUTCOMES>
</SELECTION_CRITERIA>
<SEARCH_METHODS MODIFIED="2008-09-22 13:19:00 +0100" MODIFIED_BY="[Empty name]">
<ELECTRONIC_SEARCHES MODIFIED="2008-09-22 13:19:00 +0100" MODIFIED_BY="[Empty name]">
<P>We searched the Cochrane Pregnancy and Childbirth Group trials register (August 2002).</P>
<P>The Cochrane Pregnancy and Childbirth Group's trials register is maintained by the Trials Search Co-ordinator and contains trials identified from:</P>
<OL>
<LI>quarterly searches of the Cochrane Central Register of Controlled Trials (CENTRAL);</LI>
<LI>monthly searches of MEDLINE;</LI>
<LI>handsearches of 30 journals and the proceedings of major conferences;</LI>
<LI>weekly current awareness search of a further 37 journals.</LI>
</OL>
<P>Details of the search strategies for CENTRAL and MEDLINE, the list of handsearched journals and conference proceedings, and the list of journals reviewed via the current awareness service can be found in the 'Search strategies for identification of studies' section within the editorial information about the Cochrane Pregnancy and Childbirth Group.</P>
<P>Trials identified through the searching activities described above are given a code (or codes) depending on the topic. The codes are linked to review topics. The Trials Search Co-ordinator searches the register for each review using these codes rather than keywords.</P>
</ELECTRONIC_SEARCHES>
</SEARCH_METHODS>
<DATA_COLLECTION MODIFIED="2008-09-22 13:19:23 +0100" MODIFIED_BY="[Empty name]">
<P>Reports of identified trials that appeared relevant to the objectives of the review were evaluated for inclusion. Both published and unpublished reports could be included. Attempts would be made to translate identified, non-English language reports. Primary authors would be contacted for additional details when necessary. Reasons for excluding apparently relevant trials are made explicit.</P>
<P>Included trials were assessed according to the following criteria:</P>
<OL>
<LI>adequate concealment of treatment allocation (eg sealed, opaque, numbered envelopes);</LI>
<LI>method of allocation to treatment (eg by computer randomisation, random number tables);</LI>
<LI>adequate documentation of how exclusions were handled after treatment allocation - to facilitate 'intention to treat' analyses;</LI>
<LI>adequate blinding of outcome assessment, where appropriate;</LI>
<LI>losses to follow-up (trials with losses of &gt; 25% will be excluded).</LI>
</OL>
<P>Data were entered directly from reports into the Review Manager software (<LINK REF="REF-RevMan-2000" TYPE="REFERENCE">RevMan 2000</LINK>) and statistical analysis performed. For dichotomous data, relative risks (RRs) and 95% confidence intervals (CIs) were calculated. Weighted mean differences (WMDs) and 95% CIs were calculated for continuous data.</P>
<P>Heterogeneity between trials would be tested using a standard chi squared test. In the presence of significant heterogeneity, a sensitivity analysis would explore the influence of high quality trials (fulfilling the criteria above) compared to those of lesser quality.</P>
</DATA_COLLECTION>
</METHODS>
<RESULTS>
<STUDY_DESCRIPTION>
<P>A single trial involving 1639 women was included. See 'Characteristics of included studies' for details.</P>
</STUDY_DESCRIPTION>
<STUDY_QUALITY>
<P>The method of randomisation permitted the risk of selection bias.</P>
</STUDY_QUALITY>
<INTERVENTION_EFFECTS>
<P>For ease of reading, those primary outcomes for which no data are available have not been listed in the summary graphs. There was no evidence of improved outcome from symphysis-fundal height measurements in this small trial.</P>
</INTERVENTION_EFFECTS>
</RESULTS>
<DISCUSSION>
<P>Tape measurement of symphysis-fundal height is simple, inexpensive and widely used during antenatal care. This is the only known attempt to evaluate this method in a randomised trial, and it therefore deserves attention despite the small size of the study. The antenatal identification of babies that were of low birthweight for gestational age was much lower in the symphysis-fundal height group (28%) than in the abdominal palpation group (48%); it is also much lower than that reported in many previous observational studies. It is difficult to understand why that should be.</P>
</DISCUSSION>
<CONCLUSIONS>
<IMPLICATIONS_PRACTICE>
<P>It would seem unwise to abandon the use of symphysis-fundal height measurement unless a much larger trial likewise suggests that it is unhelpful.</P>
</IMPLICATIONS_PRACTICE>
<IMPLICATIONS_RESEARCH>
<P>Clear guidance about the value of symphysis-fundal height measurement in routine antenatal care requires a much larger trial than has been performed to date.</P>
</IMPLICATIONS_RESEARCH>
</CONCLUSIONS>
</BODY>
<ACKNOWLEDGEMENTS>
<P>None</P>
</ACKNOWLEDGEMENTS>
<CONFLICT_OF_INTEREST>
<P>None known<BR/> </P>
</CONFLICT_OF_INTEREST>
<CONTRIBUTIONS>
<P>JP Neilson prepared and maintains the review.</P>
</CONTRIBUTIONS>
<PRO_REV_DIFF/>
<PUBLIC_NOTES>
<P>A new protocol to update the 'Symphysis-fundal height measurement in pregnancy' review is currently being prepared by a new review team. The title of the new protocol will be 'Symphysial fundal height measurement (SFH) in pregnancy for detecting abnormal fetal growth'.</P>
</PUBLIC_NOTES>
</MAIN_TEXT>
<STUDIES_AND_REFERENCES>
<STUDIES>
<INCLUDED_STUDIES>
<STUDY DATA_SOURCE="PUB" ID="STD-Copenhagen-1990" NAME="Copenhagen 1990" YEAR="05650">
<REFERENCE NOTES="&lt;p&gt;[5650]&lt;/p&gt;" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Lindhard A, Nielsen PV, Mouritsen LA, Zachariassen A, Sorensen HU, Roseno H</AU>
<TI>The implications of introducing the symphyseal-fundal height-measurement. A prospective randomized controlled trial</TI>
<SO>British Journal of Obstetrics and Gynaecology</SO>
<YR>1990</YR>
<VL>97</VL>
<PG>675-80</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
</INCLUDED_STUDIES>
<EXCLUDED_STUDIES/>
<AWAITING_STUDIES/>
<ONGOING_STUDIES/>
</STUDIES>
<OTHER_REFERENCES>
<ADDITIONAL_REFERENCES>
<REFERENCE ID="REF-Bailey-1989" NAME="Bailey 1989" TYPE="JOURNAL_ARTICLE">
<AU>Bailey SM, Sarmandal P, Grant JM</AU>
<TI>A comparison of three methods of assessing inter-observer variation applied to measurement of the symphysis-fundal height</TI>
<SO>British Journal of Obstetrics and Gynaecology</SO>
<YR>1989</YR>
<VL>96</VL>
<PG>1266-71</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Belizan-1978" NAME="Belizan 1978" TYPE="JOURNAL_ARTICLE">
<AU>Belizan JM, Villar J, Nardin JC, Malamud J, De Vicurna LS</AU>
<TI>Diagnosis of intrauterine growth retardation by a simple clinical method: measurement of uterine height</TI>
<SO>American Journal of Obstetrics and Gynecology</SO>
<YR>1978</YR>
<VL>131</VL>
<PG>643-6</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Hall-1980" NAME="Hall 1980" TYPE="JOURNAL_ARTICLE">
<AU>Hall M, Chng PK, MacGillivray I</AU>
<TI>Is routine antenatal care worthwhile?</TI>
<SO>Lancet</SO>
<YR>1980</YR>
<VL>ii</VL>
<PG>78-80</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Neilson-2003" NAME="Neilson 2003" NOTES="&lt;p&gt;This record should be cited as: Neilson JP. Ultrasound for fetal assessment in early pregnancy. Cochrane Database of Systematic Reviews 1998, Issue 4. Art. No.: CD000182. DOI: 10.1002/14651858.CD000182.&lt;/p&gt;" TYPE="COCHRANE_REVIEW">
<AU>Neilson JP</AU>
<TI>Ultrasound for fetal assessment in early pregnancy</TI>
<SO>Cochrane Database of Systematic Reviews</SO>
<YR>1998</YR>
<NO>4</NO>
<IDENTIFIERS>
<IDENTIFIER TYPE="OTHER" VALUE="CD000182. DOI: 10.1002/14651858.CD000182"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-RevMan-2000" NAME="RevMan 2000" TYPE="COMPUTER_PROGRAM">
<TI>Review Manager (RevMan)</TI>
<YR>2000</YR>
<EN>4.1 for Windows</EN>
<PB>The Cochrane Collaboration</PB>
<CY>Oxford, England</CY>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Rosenberg-1982" NAME="Rosenberg 1982" TYPE="JOURNAL_ARTICLE">
<AU>Rosenberg K, Grant JM, Hepburn M</AU>
<TI>Antenatal detection of growth retardation: actual practice in a large maternity hospital</TI>
<SO>British Journal of Obstetrics and Gynaecology</SO>
<YR>1982</YR>
<VL>89</VL>
<PG>12-5</PG>
<IDENTIFIERS/>
</REFERENCE>
</ADDITIONAL_REFERENCES>
<OTHER_VERSIONS_REFERENCES/>
<PENDING_REFERENCES/>
</OTHER_REFERENCES>
</STUDIES_AND_REFERENCES>
<CHARACTERISTICS_OF_STUDIES>
<CHARACTERISTICS_OF_INCLUDED_STUDIES SORT_BY="STUDY" USER_DEF_1_ENABLED="NO" USER_DEF_2_ENABLED="NO" USER_DEF_3_ENABLED="NO">
<INCLUDED_CHAR STUDY_ID="STD-Copenhagen-1990">
<CHAR_METHODS>
<P>Sealed, opaque, but unnumbered envelopes containing a project number - an odd number resulted in allocation to the experimental group; an even number to the control group.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS>
<P>Pregnant women usually at around 14 weeks of pregnancy. After allocation, 21 women with twin pregnancies were withdrawn as were 13 women with uncertain dates, and 60 because antenatal care took place elsewhere.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS>
<P>Symphysis-fundal height measurements routinely performed from 28 weeks and the results plotted on a locally derived centile chart. Control group women had observations made with a fabric strip without a measurement scale.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES>
<P>Indices of obstetric care and fetal outcome.</P>
</CHAR_OUTCOMES>
<CHAR_NOTES/>
</INCLUDED_CHAR>
<FOOTNOTES/>
</CHARACTERISTICS_OF_INCLUDED_STUDIES>
<CHARACTERISTICS_OF_EXCLUDED_STUDIES SORT_BY="STUDY">
<FOOTNOTES/>
</CHARACTERISTICS_OF_EXCLUDED_STUDIES>
<CHARACTERISTICS_OF_AWAITING_STUDIES SORT_BY="STUDY" USER_DEF_1_ENABLED="NO" USER_DEF_2_ENABLED="NO" USER_DEF_3_ENABLED="NO">
<FOOTNOTES/>
</CHARACTERISTICS_OF_AWAITING_STUDIES>
<CHARACTERISTICS_OF_ONGOING_STUDIES SORT_BY="STUDY" USER_DEF_1_ENABLED="NO" USER_DEF_2_ENABLED="NO" USER_DEF_3_ENABLED="NO">
<FOOTNOTES/>
</CHARACTERISTICS_OF_ONGOING_STUDIES>
</CHARACTERISTICS_OF_STUDIES>
<QUALITY_ITEMS>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-01" LEVEL="STUDY" NO="1">
<NAME>Adequate sequence generation?</NAME>
<DESCRIPTION>
<P>Was the allocation sequence adequately generated?</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA/>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-02" LEVEL="STUDY" NO="2">
<NAME>Allocation concealment?</NAME>
<DESCRIPTION>
<P>Was allocation adequately concealed?</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY RESULT="NO" STUDY_ID="STD-Copenhagen-1990">
<DESCRIPTION>
<P>C - Inadequate</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-03" LEVEL="GROUP" NO="3">
<NAME>Blinding?</NAME>
<DESCRIPTION>
<P>Was knowledge of the allocated interventions adequately prevented during the study?</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA/>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-04" LEVEL="GROUP" NO="4">
<NAME>Incomplete outcome data addressed?</NAME>
<DESCRIPTION>
<P>Were incomplete outcome data adequately addressed?</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA/>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-05" LEVEL="STUDY" NO="5">
<NAME>Free of selective reporting?</NAME>
<DESCRIPTION>
<P>Are reports of the study free of suggestion of selective outcome reporting?</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA/>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-06" LEVEL="STUDY" NO="6">
<NAME>Free of other bias?</NAME>
<DESCRIPTION>
<P>Was the study apparently free of other problems that could put it at a high risk of bias?</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA/>
</QUALITY_ITEM>
</QUALITY_ITEMS>
<SOF_TABLES/>
<ADDITIONAL_TABLES/>
<ANALYSES_AND_DATA CALCULATED_DATA="YES">
<COMPARISON ID="CMP-001" NO="1">
<NAME>Routine symphysis-fundal height measurement</NAME>
<DICH_OUTCOME CHI2="0.0" CI_END="4.082924901592673" CI_START="0.38111091187832835" CI_STUDY="95" CI_TOTAL="95" DF="0.0" EFFECT_MEASURE="PETO_OR" EFFECT_SIZE="1.247416222588402" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="5" I2="0.0" I2_Q="0.0" ID="CMP-001.11" LOG_CI_END="0.6109713918936445" LOG_CI_START="-0.41894861643197334" LOG_EFFECT_SIZE="0.09601138773083556" METHOD="PETO" NO="11" P_CHI2="1.0" P_Q="1.0" P_Z="0.7147947591824018" Q="0.0" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="804" TOTAL_2="835" WEIGHT="100.0" Z="0.3654242281671535">
<NAME>Perinatal mortality</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1/>
<GRAPH_LABEL_2/>
<DICH_DATA CI_END="4.082924901592673" CI_START="0.38111091187832835" EFFECT_SIZE="1.247416222588402" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="5" LOG_CI_END="0.6109713918936445" LOG_CI_START="-0.41894861643197334" LOG_EFFECT_SIZE="0.09601138773083556" ORDER="15847" O_E="0.6040268456375841" SE="0.6049801110767316" STUDY_ID="STD-Copenhagen-1990" TOTAL_1="804" TOTAL_2="835" VAR="2.732233458777308" WEIGHT="100.0"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="2.307646833868035" CI_START="0.37808126907420025" CI_STUDY="95" CI_TOTAL="95" DF="0.0" EFFECT_MEASURE="PETO_OR" EFFECT_SIZE="0.934065331507324" ESTIMABLE="YES" EVENTS_1="9" EVENTS_2="10" I2="0.0" I2_Q="0.0" ID="CMP-001.12" LOG_CI_END="0.3631693444150935" LOG_CI_START="-0.4224148379488061" LOG_EFFECT_SIZE="-0.029622746766856226" METHOD="PETO" NO="12" P_CHI2="1.0" P_Q="1.0" P_Z="0.8824908731519137" Q="0.0" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="804" TOTAL_2="835" WEIGHT="100.00000000000001" Z="0.14781233657602885">
<NAME>Apgar score &lt; 4 (1 minute)</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1/>
<GRAPH_LABEL_2/>
<DICH_DATA CI_END="2.307646833868035" CI_START="0.37808126907420025" EFFECT_SIZE="0.934065331507324" ESTIMABLE="YES" EVENTS_1="9" EVENTS_2="10" LOG_CI_END="0.3631693444150935" LOG_CI_START="-0.4224148379488061" LOG_EFFECT_SIZE="-0.029622746766856226" ORDER="15848" O_E="-0.3203172666259917" SE="0.46145603742497354" STUDY_ID="STD-Copenhagen-1990" TOTAL_1="804" TOTAL_2="835" VAR="4.696121613868972" WEIGHT="100.00000000000001"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="4.1667112985161285" CI_START="0.258950259183234" CI_STUDY="95" CI_TOTAL="95" DF="0.0" EFFECT_MEASURE="PETO_OR" EFFECT_SIZE="1.0387352745971714" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="4" I2="0.0" I2_Q="0.0" ID="CMP-001.13" LOG_CI_END="0.6197934102713041" LOG_CI_START="-0.5867836499606576" LOG_EFFECT_SIZE="0.016504880155323268" METHOD="PETO" NO="13" P_CHI2="1.0" P_Q="1.0" P_Z="0.9572370769248806" Q="0.0" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="804" TOTAL_2="835" WEIGHT="100.0" Z="0.05362106033636087">
<NAME>Apgar score &lt; 4 (5 minutes)</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1/>
<GRAPH_LABEL_2/>
<DICH_DATA CI_END="4.1667112985161285" CI_START="0.258950259183234" EFFECT_SIZE="1.0387352745971714" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="4" LOG_CI_END="0.6197934102713041" LOG_CI_START="-0.5867836499606576" LOG_EFFECT_SIZE="0.016504880155323268" ORDER="15849" O_E="0.07565588773642462" SE="0.7087493378330281" STUDY_ID="STD-Copenhagen-1990" TOTAL_1="804" TOTAL_2="835" VAR="1.9907405723769442" WEIGHT="100.0"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="1.161226367141176" CI_START="0.3904929638673401" CI_STUDY="95" CI_TOTAL="95" DF="0.0" EFFECT_MEASURE="PETO_OR" EFFECT_SIZE="0.6733875004971965" ESTIMABLE="YES" EVENTS_1="25" EVENTS_2="36" I2="0.0" I2_Q="0.0" ID="CMP-001.14" LOG_CI_END="0.06491688848749459" LOG_CI_START="-0.4083867870904405" LOG_EFFECT_SIZE="-0.17173494930147296" METHOD="PETO" NO="14" P_CHI2="1.0" P_Q="1.0" P_Z="0.15493377564533278" Q="0.0" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="196" TOTAL_2="201" WEIGHT="100.0" Z="1.4223186207320078">
<NAME>Umbilical artery pH &lt; 7.15</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1/>
<GRAPH_LABEL_2/>
<DICH_DATA CI_END="1.161226367141176" CI_START="0.3904929638673401" EFFECT_SIZE="0.6733875004971965" ESTIMABLE="YES" EVENTS_1="25" EVENTS_2="36" LOG_CI_END="0.06491688848749459" LOG_CI_START="-0.4083867870904405" LOG_EFFECT_SIZE="-0.17173494930147296" ORDER="15850" O_E="-5.115869017632242" SE="0.27802092192545885" STUDY_ID="STD-Copenhagen-1990" TOTAL_1="196" TOTAL_2="201" VAR="12.937341487766908" WEIGHT="100.0"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="1.6508513295576934" CI_START="0.6894253296534127" CI_STUDY="95" CI_TOTAL="95" DF="0.0" EFFECT_MEASURE="PETO_OR" EFFECT_SIZE="1.0668358458962126" ESTIMABLE="YES" EVENTS_1="43" EVENTS_2="42" I2="0.0" I2_Q="0.0" ID="CMP-001.15" LOG_CI_END="0.2177079638382223" LOG_CI_START="-0.1615127645506094" LOG_EFFECT_SIZE="0.02809759964380646" METHOD="PETO" NO="15" P_CHI2="1.0" P_Q="1.0" P_Z="0.7714802550925951" Q="0.0" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="804" TOTAL_2="835" WEIGHT="100.0" Z="0.29043920456489447">
<NAME>Admission neonatal unit</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1/>
<GRAPH_LABEL_2/>
<DICH_DATA CI_END="1.6508513295576934" CI_START="0.6894253296534127" EFFECT_SIZE="1.0668358458962126" ESTIMABLE="YES" EVENTS_1="43" EVENTS_2="42" LOG_CI_END="0.2177079638382223" LOG_CI_START="-0.1615127645506094" LOG_EFFECT_SIZE="0.02809759964380646" ORDER="15851" O_E="1.303843807199513" SE="0.2227561330284799" STUDY_ID="STD-Copenhagen-1990" TOTAL_1="804" TOTAL_2="835" VAR="20.15304431370866" WEIGHT="100.0"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="4.386858766728062" CI_START="0.8457818331970808" CI_STUDY="95" CI_TOTAL="95" DF="0.0" EFFECT_MEASURE="PETO_OR" EFFECT_SIZE="1.9262205091058358" ESTIMABLE="YES" EVENTS_1="15" EVENTS_2="8" I2="0.0" I2_Q="0.0" ID="CMP-001.16" LOG_CI_END="0.6421536526821251" LOG_CI_START="-0.07274164743101261" LOG_EFFECT_SIZE="0.28470600262555623" METHOD="PETO" NO="16" P_CHI2="1.0" P_Q="1.0" P_Z="0.11849884814965539" Q="0.0" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="804" TOTAL_2="835" WEIGHT="100.0" Z="1.5611055527715636">
<NAME>Antepartum hospitalization for 'IUGR'</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1/>
<GRAPH_LABEL_2/>
<DICH_DATA CI_END="4.386858766728062" CI_START="0.8457818331970808" EFFECT_SIZE="1.9262205091058358" ESTIMABLE="YES" EVENTS_1="15" EVENTS_2="8" LOG_CI_END="0.6421536526821251" LOG_CI_START="-0.07274164743101261" LOG_EFFECT_SIZE="0.28470600262555623" ORDER="15852" O_E="3.7175106772422204" SE="0.41993303807526555" STUDY_ID="STD-Copenhagen-1990" TOTAL_1="804" TOTAL_2="835" VAR="5.670742304882454" WEIGHT="100.0"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="1.5945069964828014" CI_START="0.4404007758602545" CI_STUDY="95" CI_TOTAL="95" DF="0.0" EFFECT_MEASURE="PETO_OR" EFFECT_SIZE="0.8379869440305319" ESTIMABLE="YES" EVENTS_1="17" EVENTS_2="21" I2="0.0" I2_Q="0.0" ID="CMP-001.17" LOG_CI_END="0.20262642920908586" LOG_CI_START="-0.35615192459690154" LOG_EFFECT_SIZE="-0.07676274769390784" METHOD="PETO" NO="17" P_CHI2="1.0" P_Q="1.0" P_Z="0.590229068799993" Q="0.0" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="804" TOTAL_2="835" WEIGHT="100.0" Z="0.5385041128011655">
<NAME>Labour induction for 'IUGR'</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1/>
<GRAPH_LABEL_2/>
<DICH_DATA CI_END="1.5945069964828014" CI_START="0.4404007758602545" EFFECT_SIZE="0.8379869440305319" ESTIMABLE="YES" EVENTS_1="17" EVENTS_2="21" LOG_CI_END="0.20262642920908586" LOG_CI_START="-0.35615192459690154" LOG_EFFECT_SIZE="-0.07676274769390784" ORDER="15853" O_E="-1.6406345332519834" SE="0.3282291710230978" STUDY_ID="STD-Copenhagen-1990" TOTAL_1="804" TOTAL_2="835" VAR="9.28208728864719" WEIGHT="100.0"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="1.6671798044912598" CI_START="0.3099175219349303" CI_STUDY="95" CI_TOTAL="95" DF="0.0" EFFECT_MEASURE="PETO_OR" EFFECT_SIZE="0.7188102904298831" ESTIMABLE="YES" EVENTS_1="9" EVENTS_2="13" I2="0.0" I2_Q="0.0" ID="CMP-001.18" LOG_CI_END="0.22198244079221852" LOG_CI_START="-0.5087538691801019" LOG_EFFECT_SIZE="-0.1433857141939416" METHOD="PETO" NO="18" P_CHI2="1.0" P_Q="1.0" P_Z="0.4417914095855848" Q="0.0" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="804" TOTAL_2="835" WEIGHT="100.0" Z="0.7691716748776982">
<NAME>Caesarean section for 'IUGR'</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1/>
<GRAPH_LABEL_2/>
<DICH_DATA CI_END="1.6671798044912602" CI_START="0.3099175219349303" EFFECT_SIZE="0.7188102904298831" ESTIMABLE="YES" EVENTS_1="9" EVENTS_2="13" LOG_CI_END="0.22198244079221863" LOG_CI_START="-0.5087538691801019" LOG_EFFECT_SIZE="-0.1433857141939416" ORDER="15854" O_E="-1.7919463087248317" SE="0.42923812568081293" STUDY_ID="STD-Copenhagen-1990" TOTAL_1="804" TOTAL_2="835" VAR="5.427544843787356" WEIGHT="100.0"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="1.982839355254594" CI_START="0.9115740685845078" CI_STUDY="95" CI_TOTAL="95" DF="0.0" EFFECT_MEASURE="PETO_OR" EFFECT_SIZE="1.3444348025913762" ESTIMABLE="YES" EVENTS_1="61" EVENTS_2="48" I2="0.0" I2_Q="0.0" ID="CMP-001.19" LOG_CI_END="0.2972875301646671" LOG_CI_START="-0.04020803762816606" LOG_EFFECT_SIZE="0.12853974626825052" METHOD="PETO" NO="19" P_CHI2="1.0" P_Q="1.0" P_Z="0.1354483064511005" Q="0.0" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="804" TOTAL_2="835" WEIGHT="100.0" Z="1.4929575218737896">
<NAME>Birthweight &lt;10th centile</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1/>
<GRAPH_LABEL_2/>
<DICH_DATA CI_END="1.982839355254594" CI_START="0.9115740685845078" EFFECT_SIZE="1.3444348025913762" ESTIMABLE="YES" EVENTS_1="61" EVENTS_2="48" LOG_CI_END="0.2972875301646671" LOG_CI_START="-0.04020803762816606" LOG_EFFECT_SIZE="0.12853974626825052" ORDER="15855" O_E="7.530811470408786" SE="0.1982465671515143" STUDY_ID="STD-Copenhagen-1990" TOTAL_1="804" TOTAL_2="835" VAR="25.444191083331006" WEIGHT="100.0"/>
</DICH_OUTCOME>
</COMPARISON>
</ANALYSES_AND_DATA>
<FIGURES/>
<FEEDBACK/>
<APPENDICES/>
<EXTENSIONS/>
</COCHRANE_REVIEW>